{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:26:28Z","timestamp":1787775988129,"version":"build-2784847793"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Hepatitis C virus (HCV) is a major issue in the field of blood transfusion safety and blood components. Serological tests are used to detect anti-HCV antibodies in blood donors. This study was performed to evaluate the status of anti-HCV antibodies in blood donors and serological assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUBJECTS AND METHODS:<\/jats:title>\n                    <jats:p>Data related to the results of screening and confirmation tests of 427,203 blood donors were examined over a 6-year period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The results showed the highest frequency of positive ELISA results 329 (% 0.39) among first-time blood donors. Out of 901 samples with reactive\/positive ELISA result, 104 (11.5%) samples had positive or IND confirmation test results which were belong to donors with a history of healthy blood donation. Antibodies against the NS3 (23%) and core (16.9%) antigens had the highest frequency among blood donors with positive\/Reactive ELISA, respectively. The core antigen was the highest immunoreactive protein. A median correlation was found between OD in the ELISA test and the antibody profile in the RIBA test (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = 0.62,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>The seroconversion in healthy blood donors is worrying in relation to the status of the disease in the community and its high incidence. Using Core and NS3 antigens assay can be helpful in screening and diagnosis or antigen detection might be the first next step following a Positive\/Reactive antibody test. The use of serological algorithm in blood transfusion centers is questionable and our research has challenged the theory that blood donors with a history of blood donation are healthier in transmitting viral infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ajts.ajts_156_21","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T15:01:50Z","timestamp":1760799710000},"page":"304-309","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Anti-hepatitis C virus antibody status and outcomes in serologic assays in blood donors"],"prefix":"10.4103","volume":"19","author":[{"given":"Majid","family":"Mohsenizadeh","sequence":"first","affiliation":[{"name":"Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taravat","family":"Bamdad","sequence":"additional","affiliation":[{"name":"Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motahareh","family":"Ghaziizadeh","sequence":"additional","affiliation":[{"name":"Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Kerman Regional Blood Transfusion Center, Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"R1-20251022","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12985-016-0572-9","article-title":"Characterization of differential antibody production against hepatitis C virus in different HCV infection status","volume":"13","author":"Rafik","year":"2016","journal-title":"Virol J"},{"key":"R2-20251022","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1186\/s12879-017-2773-2","article-title":"Diagnostic accuracy of tests to detect Hepatitis C antibody:A meta-analysis and review of the literature","volume":"17","author":"Tang","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R3-20251022","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/15321819.2016.1241264","article-title":"Prevalence of anti-hepatitis C virus antibody among pregnant women and blood donors at Bowen University Teaching Hospital, Ogbomoso, Oyo State, Nigeria","volume":"38","author":"Hilda","year":"2017","journal-title":"J Immunoassay Immunochem"},{"key":"R4-20251022","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection","volume":"5","author":"Rehermann","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R5-20251022","first-page":"e106273","article-title":"Evaluation of a novel enzyme-linked immuno assay model to detect E2 antigen and antibodies against core, NS3, NS4, and NS5 antigens of hepatitis C virus","volume":"20","author":"Kargar","year":"2020","journal-title":"Hepat Mon"},{"key":"R6-20251022","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J Hepatol"},{"key":"R7-20251022","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1743-422X-6-84","article-title":"Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection","volume":"6","author":"Sillanp\u00e4\u00e4","year":"2009","journal-title":"Virol J"},{"key":"R9-20251022","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0973-6247.126683","article-title":"Hepatitis C virus:Screening, diagnosis, and interpretation of laboratory assays","volume":"8","author":"Gupta","year":"2014","journal-title":"Asian J Transfus Sci"},{"key":"R10-20251022","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4254\/wjh.v7.i10.1377","article-title":"Hepatitis C virus:Virology, diagnosis and treatment","volume":"7","author":"Li","year":"2015","journal-title":"World J Hepatol"},{"key":"R12-20251022","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1128\/JCM.01064-10","article-title":"Distinguishing acute from chronic hepatitis C virus (HCV) infection based on antibody reactivities to specific HCV structural and nonstructural proteins","volume":"49","author":"Araujo","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R13-20251022","doi-asserted-by":"crossref","first-page":"e20180491","DOI":"10.1590\/0037-8682-0491-2018","article-title":"IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus","volume":"52","author":"Santos","year":"2019","journal-title":"Rev Soc Bras Med Trop"},{"key":"R14-20251022","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3855\/jidc.11426","article-title":"Evaluation of biochemical, hematological, RIBA and PCR assays in predicting viremia in anti-HCV positive patients","volume":"13","author":"Sirin","year":"2019","journal-title":"J Infect Dev Ctries"},{"issue":"Suppl 3","key":"R15-20251022","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.ijid.2009.11.032","article-title":"Seroprevalence of hepatitis C virus:The first population-based study from Iran","volume":"14","author":"Merat","year":"2010","journal-title":"Int J Infect Dis"},{"key":"R16-20251022","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/vim.2013.0064","article-title":"How to interpret borderline HCV antibody test results:A comparative study investigating four different anti-HCV assays","volume":"27","author":"Maasoumy","year":"2014","journal-title":"Viral Immunol"},{"key":"R17-20251022","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12288-012-0213-4","article-title":"Rate of seroconversion in repeat blood donors at the national blood centre, Kuala Lumpur","volume":"30","author":"Nafishah","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R18-20251022","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1002\/hep.1840360709","article-title":"Use and interpretation of virological tests for hepatitis C","volume":"36","author":"Pawlotsky","year":"2002","journal-title":"Hepatology"},{"key":"R19-20251022","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00005-013-0257-7","article-title":"Seronegative hepatitis C virus infection","volume":"62","author":"Ka\u017amierczak","year":"2014","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"R20-20251022","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3390\/ijms18081626","article-title":"Unsolved puzzles surrounding HCV immunity:Heterologous immunity adds another dimension","volume":"18","author":"Agrawal","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R21-20251022","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1128\/JCM.01440-06","article-title":"Combined hepatitis C virus (HCV) antigen-antibody detection assay does not improve diagnosis for seronegative individuals with occult HCV infection","volume":"44","author":"Quiroga","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R22-20251022","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12985-021-01608-x","article-title":"Astudy based on four immunoassays:Hepatitis C virus antibody against different antigens may have unequal contributions to detection","volume":"18","author":"Jiang","year":"2021","journal-title":"Virol J"},{"key":"R23-20251022","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7150\/ijbs.5.421","article-title":"HCV antibody response and genotype distribution in different areas and races of China","volume":"5","author":"Jia","year":"2009","journal-title":"Int J Biol Sci"},{"key":"R24-20251022","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.3748\/wjg.v20.i11.2948","article-title":"Current testing strategies for hepatitis C virus infection in blood donors and the way forward","volume":"20","author":"Marwaha","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R25-20251022","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1111\/trf.14951","article-title":"Incidence rates of hepatitis C virus infection among blood donors in Japan:A nationwide retrospective cohort study","volume":"58","author":"Uchida","year":"2018","journal-title":"Transfusion"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.AJTS_156_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:47:57Z","timestamp":1787773677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.AJTS_156_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ajts.ajts_156_21","relation":{},"ISSN":["0973-6247","1998-3565"],"issn-type":[{"value":"0973-6247","type":"print"},{"value":"1998-3565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"2021-10-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}